This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2014 Jun 26;370(26):2515-9.

doi: 10.1056/NEJMra1401468.

Prophylaxis against venous thromboembolism in ambulatory patients with cancer

Jean M Connors¹

Affiliations

PMID: 24963570
DOI: 10.1056/NEJMra1401468

Review

Prophylaxis against venous thromboembolism in ambulatory patients with cancer

Jean M Connors. N Engl J Med. 2014.

. 2014 Jun 26;370(26):2515-9.

doi: 10.1056/NEJMra1401468.

Author

Jean M Connors¹

Affiliation

¹ From the Hematology Division, Brigham and Women's Hospital, and Dana-Farber Cancer Institute - both in Boston.

PMID: 24963570
DOI: 10.1056/NEJMra1401468

No abstract available

PubMed Disclaimer

Comment in

Prophylaxis against venous thromboembolism in patients with cancer.
Connors JM. Connors JM. N Engl J Med. 2014 Sep 25;371(13):1263-4. doi: 10.1056/NEJMc1408866. N Engl J Med. 2014. PMID: 25251624 No abstract available.
Prophylaxis against venous thromboembolism in patients with cancer.
Verso M, Agnelli G. Verso M, et al. N Engl J Med. 2014 Sep 25;371(13):1262. doi: 10.1056/NEJMc1408866. N Engl J Med. 2014. PMID: 25251625 No abstract available.
Prophylaxis against venous thromboembolism in patients with cancer.
Porfidia A, Morretti T, Landolfi R. Porfidia A, et al. N Engl J Med. 2014 Sep 25;371(13):1262-3. doi: 10.1056/NEJMc1408866. N Engl J Med. 2014. PMID: 25251626 No abstract available.

Similar articles

Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB, Rivey MP, Hansen CJ. Aikens GB, et al. Ann Pharmacother. 2013 Feb;47(2):198-209. doi: 10.1345/aph.1R335. Epub 2013 Feb 5. Ann Pharmacother. 2013. PMID: 23386067 Review.
The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
Squizzato A, Ageno W. Squizzato A, et al. Thromb Haemost. 2009 Jan;101(1):31-5. Thromb Haemost. 2009. PMID: 19132186 Review. No abstract available.
[Cancer and venous thromboembolism].
Rasmussen MS, Münster AM. Rasmussen MS, et al. Ugeskr Laeger. 2010 Mar 22;172(12):958. Ugeskr Laeger. 2010. PMID: 20334792 Danish. No abstract available.
[Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S, Wendtner CM. Struve S, et al. Dtsch Med Wochenschr. 2012 Oct;137(40):2007-9. doi: 10.1055/s-0032-1305301. Epub 2012 Sep 17. Dtsch Med Wochenschr. 2012. PMID: 22987155 German. No abstract available.
Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines.
Lyman GH, Kuderer NM; American Society of Clinical Oncology. Lyman GH, et al. Thromb Res. 2010 Apr;125 Suppl 2:S120-7. doi: 10.1016/S0049-3848(10)70029-3. Thromb Res. 2010. PMID: 20433991 No abstract available.

See all similar articles

Cited by

Venous thromboembolism in hematopoietic stem cell transplant recipients.
Chaturvedi S, Neff A, Nagler A, Savani U, Mohty M, Savani BN. Chaturvedi S, et al. Bone Marrow Transplant. 2016 Apr;51(4):473-8. doi: 10.1038/bmt.2015.308. Epub 2015 Dec 21. Bone Marrow Transplant. 2016. PMID: 26691425 Review.
Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway.
Pfankuchen DB, Baltes F, Batool T, Li JP, Schlesinger M, Bendas G. Pfankuchen DB, et al. Oncotarget. 2017 Jun 28;8(40):67553-67566. doi: 10.18632/oncotarget.18738. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978053 Free PMC article.
Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study.
Abdel-Razeq H, Tamimi F, Abdel-Razeq R, Salah S, Omari Z, Salama O, Abufara A, Al-Tell A, Qahoush H, Nasman A, Taqash A, Alhalaseh Y, Bater R. Abdel-Razeq H, et al. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211024756. doi: 10.1177/10760296211024756. Clin Appl Thromb Hemost. 2021. PMID: 34121471 Free PMC article.
Safety assessment of concurrent statin treatment and evaluation of drug interactions in China.
Yan MM, Wu SS, Ying YQ, Lu N, Zhong MK. Yan MM, et al. SAGE Open Med. 2018 Oct 11;6:2050312118798278. doi: 10.1177/2050312118798278. eCollection 2018. SAGE Open Med. 2018. PMID: 30345053 Free PMC article.
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial.
Khorana AA, McNamara MG, Kakkar AK, Streiff MB, Riess H, Vijapurkar U, Kaul S, Wildgoose P, Soff GA; CASSINI Investigators. Khorana AA, et al. TH Open. 2020 May 23;4(2):e107-e112. doi: 10.1055/s-0040-1712143. eCollection 2020 Apr. TH Open. 2020. PMID: 32462111 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information